Acrivon snags $100M to bring Lilly cancer drug into 19th study
12 Nov 2021 //
FIERCEBIOTECH
Boosting I-O by targeting a cellular stress pathway
27 Oct 2021 //
FIERCEBIOTECH
Analysts to Lilly: Why did Trulicity and Taltz come up short?
01 May 2019 //
FIERCE PHARMA
Lilly dumps phase 2 cancer drugs that survived previous cull
30 Apr 2019 //
FIERCE BIOTECH
Suffering a series of setbacks, Eli Lilly’s oncology executes 2 of its top drugs
30 Apr 2019 //
ENDPTS